Moreover, these studies have suggested other indicators that are more sensitive in predicting AAA progression, such as c-reactive protein (CRP), insulin-like growth factor 1 (IGF-1), antiphospholipid (APL) antibodies, and matrix metalloproteinase-9 (MMP-9) (4). This evidence concerns the gene MMP9 and acute promyelocytic leukemia.